Cresilon advises the financing will support the company’s efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
October 27, 2022
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Cresilon advises the financing will support the company’s efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.